Genetic Variants and Complex Trait Analysis

Genetic variants encompass single‐nucleotide changes, insertions, deletions and larger structural differences in DNA that influence gene function and regulation. The analysis of complex traits—such as height, metabolic measures and susceptibility to common diseases—relies on detecting and interpreting the combined effects of many such variants. Large‐scale population cohorts and biobanks, together with genome‐wide association studies and advanced statistical models, have revealed that both rare, high‐impact alleles and common, low‐effect polymorphisms contribute to trait variation. Integrative approaches, including fine‐mapping, gene expression profiling and in silico prediction of variant impact, have begun to unravel the biological pathways underlying associations and to enable polygenic risk prediction. These developments hold promise for precision medicine, allowing risk stratification, identification of causal mechanisms and the prioritisation of therapeutic targets across diverse populations.

Research from Nature Portfolio

Recent studies have leveraged data from a population isolate of over 200,000 Finnish participants to uncover low‐frequency variants enriched by historical bottlenecks. Analysis of more than 15 disease end points identified novel associations at dozens of loci, many implicating coding changes with large phenotypic effects. Fine‐mapping pinpointed causal variants that are rare in broader European cohorts but enriched in Finland, demonstrating the power of isolated populations to illuminate biology of common diseases.

Another major contribution aggregated over 125,000 exome sequences and 15,000 whole genomes into a comprehensive variant resource. By classifying human protein‐coding genes along a spectrum of tolerance to inactivation, this work defined a mutational constraint landscape that informs gene discovery across both rare disorders and complex traits. The resulting catalogue of high‐confidence loss‐of‐function variants underpins improved statistical power in association studies and guides functional experiments.

Genetic Variants and Complex Trait Analysis publication trend

The graph below shows the total number of articles in genetic variants and complex trait analysis across all publications each year (not limited to Nature Index journals).

Technical terms

Genome‐wide association study (GWAS): A survey of common genetic variants across the genome in large cohorts to detect statistical associations with traits or diseases.

Polygenic risk score (PRS): An aggregate measure of genetic predisposition calculated by summing the effects of multiple trait-associated variants.

Loss‐of‐function variant: A DNA change predicted to disrupt or inactivate a protein-coding gene, often under strong negative selection and found at low frequency.

Mendelian randomisation (MR): A causal inference method that uses genetic variants as instrumental variables to assess the effect of an exposure on an outcome.

References

1. Biomarker and genomic analyses reveal molecular signatures of non-cardioembolic ischemic stroke. Signal Transduction and Targeted Therapy (2023).
2. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature (2023).
3. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature (2020).
4. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genetic Epidemiology (2016).